Americans head to Canada to buy cheap insulin, leading to worries about supply

spaminator

Hall of Fame Member
Oct 26, 2009
38,861
3,572
113
Canadian minister to meet with drug industry, others on U.S. import plan
Reuters
Published:
August 6, 2019
Updated:
August 6, 2019 3:49 PM EDT
Minister of Health Ginette Petitpas Taylor speaks at a press conference regarding the Canada Food Guide and her letter to Conservative leader Andrew Scheer, at the National Press Theatre in Ottawa on Monday, July 22, 2019.Justin Tang / THE CANADIAN PRESS
TORONTO — Canada’s health minister will meet with pharmacists, patients, industry and experts on Monday to discuss the impact of recent moves by the U.S. government to import drugs from Canada, the federal minister said on Tuesday, responding to concerns about possible drug shortages and higher costs.
The Trump administration last week announced that it would propose a rule to allow U.S. states and other groups to start pilot programs importing pharmaceuticals from Canada as part of an effort to lower costs.
“Our government is focused on ensuring Canadians have consistent access to medications they rely on,” Canadian health minister Ginette Petitpas Taylor said in a tweet.
She said the meeting would look at “next steps to safeguard Canada’s prescription drug supply.”
Pharmacists, patient groups and others have argued that large-scale shipments from Canada to the United States could cause medication shortages or raise costs in Canada.
Canada’s main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding to the Trump administration’s plans, Reuters reported on Monday.
Andrew Scheer promises premiers health transfer increase in anticipation of attacks
Canadians may experience EpiPen shortage: Health Canada
In 2005, an earlier Canadian government promised a bill that would restrict drug exports in response to similar U.S. proposals but never passed the law.
A spokesman from the minister’s office said last week that the government was “examining all options” to ensure the country’s drug supply is secure.
http://torontosun.com/news/national...-with-drug-industry-others-on-u-s-import-plan
 

spilledthebeer

Executive Branch Member
Jan 26, 2017
9,296
4
36
Canadian minister to meet with drug industry, others on U.S. import plan
Reuters
Published:
August 6, 2019
Updated:
August 6, 2019 3:49 PM EDT
Minister of Health Ginette Petitpas Taylor speaks at a press conference regarding the Canada Food Guide and her letter to Conservative leader Andrew Scheer, at the National Press Theatre in Ottawa on Monday, July 22, 2019.Justin Tang / THE CANADIAN PRESS
TORONTO — Canada’s health minister will meet with pharmacists, patients, industry and experts on Monday to discuss the impact of recent moves by the U.S. government to import drugs from Canada, the federal minister said on Tuesday, responding to concerns about possible drug shortages and higher costs.
The Trump administration last week announced that it would propose a rule to allow U.S. states and other groups to start pilot programs importing pharmaceuticals from Canada as part of an effort to lower costs.
“Our government is focused on ensuring Canadians have consistent access to medications they rely on,” Canadian health minister Ginette Petitpas Taylor said in a tweet.
She said the meeting would look at “next steps to safeguard Canada’s prescription drug supply.”
Pharmacists, patient groups and others have argued that large-scale shipments from Canada to the United States could cause medication shortages or raise costs in Canada.
Canada’s main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding to the Trump administration’s plans, Reuters reported on Monday.
Andrew Scheer promises premiers health transfer increase in anticipation of attacks
Canadians may experience EpiPen shortage: Health Canada
In 2005, an earlier Canadian government promised a bill that would restrict drug exports in response to similar U.S. proposals but never passed the law.
A spokesman from the minister’s office said last week that the government was “examining all options” to ensure the country’s drug supply is secure.
http://torontosun.com/news/national...-with-drug-industry-others-on-u-s-import-plan




Federal LIE-berals have promised us a "new pharmacare" drug plan.............................................


in hope of buying our votes!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


And yet.................................


the federal LIE-beral plan looks suspiciously like the Wynne-bag Ontari-owe LIE-beral pharmacare plan..............................


THAT WAS ONLY HALF FUNDED!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


And had ALL SORTS OF LOOPHOLES..............................


so that drug companies and insurance providers.................................


COULD WIN BIG!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


By passing on all sorts of obligations to the govt pay system.................................


so that Big Drug Companies would have the PROFITS NEEDED........................


to pay BIG DIVIDENDS to civil service union stock holders!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


LIE-berals do enjoy building profitable business opportunities!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


Such as the Ontari-owe auto insurance MESS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


Where Ontari-owe has THE BEST DRIVING RECORD IN CANADA!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


ALONG WITH THE HIGHEST INSURANCE RATES!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!



It is easy to determine when a LIE-berals is issuing Fake News..............................


because the Fakery includes AN APPEAL FOR YOUR VOTE.............................


in exchange for some woefully underfunded LIE-beral promise..........................


that is full of loopholes that COST YOU....................................


and EXCUSE LIE-berals from responsibility!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
 

spaminator

Hall of Fame Member
Oct 26, 2009
38,861
3,572
113
Ottawa keeping tabs as doctors sound alarm about cancer drug supply
Canadian Press
Published:
August 7, 2019
Updated:
August 7, 2019 8:35 AM EDT
Etoposide. SunMedia
OTTAWA — The federal health minister’s office says it is keeping a close watch on the supply of three generic cancer drugs as doctors raise serious concerns about the risk of critical shortages across Canada.
The intravenous drugs in question are etoposide, vinorelbine and leucovorin.
Ginnette Petitpas Taylor’s spokesperson Alexander Cohen says the government has facilitated the importation of an international supply of etoposide in the short term.
Cohen says companies are conserving existing supply for patients and the shortage for that particular drug is expected to be over by the end of September.
In the case of vinorelbine, he says the company Generic Medical Partners Inc. is putting in place a distribution plan to supply 75% of demand for current orders by October and is also increasing production.
For leucovorin, Cohen says the federal government is working with companies on options to import an international supply as soon as possible.
New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study
Drug company used rap video to push for higher fentanyl doses, sales
“We’re closely monitoring the supply of each of the three cancer drugs, and have taken specific measures to ensure Canadians continue to have access to them,” he said in a statement.
CBC News reported on the weekend that hospitals in Ontario, Quebec, Nova Scotia and New Brunswick have been scrambling to find alternatives and make existing supplies of the drugs last as long as possible.
http://torontosun.com/news/national...-doctors-sound-alarm-about-cancer-drug-supply
 

spilledthebeer

Executive Branch Member
Jan 26, 2017
9,296
4
36
Ottawa keeping tabs as doctors sound alarm about cancer drug supply
Canadian Press
Published:
August 7, 2019
Updated:
August 7, 2019 8:35 AM EDT
Etoposide. SunMedia
OTTAWA — The federal health minister’s office says it is keeping a close watch on the supply of three generic cancer drugs as doctors raise serious concerns about the risk of critical shortages across Canada.
The intravenous drugs in question are etoposide, vinorelbine and leucovorin.
Ginnette Petitpas Taylor’s spokesperson Alexander Cohen says the government has facilitated the importation of an international supply of etoposide in the short term.
Cohen says companies are conserving existing supply for patients and the shortage for that particular drug is expected to be over by the end of September.
In the case of vinorelbine, he says the company Generic Medical Partners Inc. is putting in place a distribution plan to supply 75% of demand for current orders by October and is also increasing production.
For leucovorin, Cohen says the federal government is working with companies on options to import an international supply as soon as possible.
New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study
Drug company used rap video to push for higher fentanyl doses, sales
“We’re closely monitoring the supply of each of the three cancer drugs, and have taken specific measures to ensure Canadians continue to have access to them,” he said in a statement.
CBC News reported on the weekend that hospitals in Ontario, Quebec, Nova Scotia and New Brunswick have been scrambling to find alternatives and make existing supplies of the drugs last as long as possible.
http://torontosun.com/news/national...-doctors-sound-alarm-about-cancer-drug-supply




Our idiot Boy Justin SAID he supported FREE TRADE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!


Is this what he had in mind?????????????????????????


Yankees raiding our medicine chest?????????????????????????????????

 

spaminator

Hall of Fame Member
Oct 26, 2009
38,861
3,572
113
Canadian drug distributors say no to Trump import plan
Reuters
Published:
December 20, 2019
Updated:
December 20, 2019 4:03 PM EST
(Getty Images)
TORONTO — Many of Canada’s drug suppliers cannot, or will not, agree to ship cheaper prescription medicines into the United States, a new challenge to the Trump administration’s push to reduce drug prices, companies and industry officials told Reuters.
The administration on Wednesday proposed new regulations that would allow states to import prescription drugs from Canada. They would require a state such as Florida to partner with a wholesaler licensed by Health Canada, which regulates drugs.
Florida and other states have said they are eager to start importation programs, and the proposal took the federal government one step closer to approving that plan. But there are practical barriers to actually bringing in drugs.
Two drug distributors and two Canadian industry groups that between them represent all of the potential suppliers named in a proposal published by Florida in August said they are not interested in participating.
“We have not been contacted and we are not planning to participate,” said Loblaw Companies Ltd, which owns Canada’s largest pharmacy chain Shoppers Drug Mart. “Canadian patients currently face product and drug shortages and we are concerned this initiative may exacerbate what is already a critical issue.”
Story continues below
Daniel Chiasson, president of the Canadian Association for Pharmacy Distribution Management (CAPDM), said none of its members would participate because their first priority was ensuring a safe and stable supply of medication for Canadians.
“It surprised everyone when their names appeared on that list,” said Chiasson.
Mary Mayhew, secretary of the Florida Agency for Health Care Administration, said she was “excited and enthusiastic” about Wednesday’s announcement.
“We are optimistic that Canadian suppliers will be interested, as the rule is understood, as there is more dialog around this new and historic federal action,” she said.
Chiasson said agreements between manufacturers and distributors prevent the export of products made for the Canadian market, creating a commercial risk and deterrent to exporting.
“These are issues we continue to consider and are committed to exploring how we might overcome any challenges and issues as we advance the proposed rule,” U.S. Food and Drug Administration spokesman Michael Felberbaum said in a statement.
Some of Canada’s major distributors are subsidiaries of U.S. companies, who are unlikely to participate in a program to lower prices, since their revenue reflects a cut of the value of the drugs they provide to pharmacies in the much larger U.S. market.
McKesson Canada, a subsidiary of McKesson Corp referred questions to Chiasson. The organization is also a listed member of the Alliance for Safe Online Pharmacies Canada, a lobby group that opposes drug exports to the United States.
AmerisourceBergen said that protecting bottom lines was not the issue, because importation implied that distributors could buy low-cost drugs and sell them in high-cost markets.
“The reality is that legal and contractual barriers, as well as significant threat to the integrity of the supply chain, all stand in the way of importation being a viable solution,” it said in a statement.
Kohl & Frisch, a large closely-held distributor, did not respond to requests for comment. Metro Inc which owns major pharmacy chain Jean Coutu, declined to comment.
One company on Florida’s list is not a distributor in any traditional sense, but makes self-serve pharmacy kiosks that resemble vending machines. They confirmed they would have no role in any import plan.
The remaining companies are members of the Association quebecoise des distributeurs en pharmacie, which takes the same position as CAPDM.
“Our members have no intention to sell drugs across the border, particularly in light of the rapidly increasing drug shortages in the Quebec marketplace,” said director general Hugues Mousseau in a statement.
http://torontosun.com/news/national/canadian-drug-distributors-say-no-to-trump-import-plan
 

spilledthebeer

Executive Branch Member
Jan 26, 2017
9,296
4
36
Canadian drug distributors say no to Trump import plan
Reuters
Published:
December 20, 2019
Updated:
December 20, 2019 4:03 PM EST
(Getty Images)
TORONTO — Many of Canada’s drug suppliers cannot, or will not, agree to ship cheaper prescription medicines into the United States, a new challenge to the Trump administration’s push to reduce drug prices, companies and industry officials told Reuters.
The administration on Wednesday proposed new regulations that would allow states to import prescription drugs from Canada. They would require a state such as Florida to partner with a wholesaler licensed by Health Canada, which regulates drugs.
Florida and other states have said they are eager to start importation programs, and the proposal took the federal government one step closer to approving that plan. But there are practical barriers to actually bringing in drugs.
Two drug distributors and two Canadian industry groups that between them represent all of the potential suppliers named in a proposal published by Florida in August said they are not interested in participating.
“We have not been contacted and we are not planning to participate,” said Loblaw Companies Ltd, which owns Canada’s largest pharmacy chain Shoppers Drug Mart. “Canadian patients currently face product and drug shortages and we are concerned this initiative may exacerbate what is already a critical issue.”
Story continues below
Daniel Chiasson, president of the Canadian Association for Pharmacy Distribution Management (CAPDM), said none of its members would participate because their first priority was ensuring a safe and stable supply of medication for Canadians.
“It surprised everyone when their names appeared on that list,” said Chiasson.
Mary Mayhew, secretary of the Florida Agency for Health Care Administration, said she was “excited and enthusiastic” about Wednesday’s announcement.
“We are optimistic that Canadian suppliers will be interested, as the rule is understood, as there is more dialog around this new and historic federal action,” she said.
Chiasson said agreements between manufacturers and distributors prevent the export of products made for the Canadian market, creating a commercial risk and deterrent to exporting.
“These are issues we continue to consider and are committed to exploring how we might overcome any challenges and issues as we advance the proposed rule,” U.S. Food and Drug Administration spokesman Michael Felberbaum said in a statement.
Some of Canada’s major distributors are subsidiaries of U.S. companies, who are unlikely to participate in a program to lower prices, since their revenue reflects a cut of the value of the drugs they provide to pharmacies in the much larger U.S. market.
McKesson Canada, a subsidiary of McKesson Corp referred questions to Chiasson. The organization is also a listed member of the Alliance for Safe Online Pharmacies Canada, a lobby group that opposes drug exports to the United States.
AmerisourceBergen said that protecting bottom lines was not the issue, because importation implied that distributors could buy low-cost drugs and sell them in high-cost markets.
“The reality is that legal and contractual barriers, as well as significant threat to the integrity of the supply chain, all stand in the way of importation being a viable solution,” it said in a statement.
Kohl & Frisch, a large closely-held distributor, did not respond to requests for comment. Metro Inc which owns major pharmacy chain Jean Coutu, declined to comment.
One company on Florida’s list is not a distributor in any traditional sense, but makes self-serve pharmacy kiosks that resemble vending machines. They confirmed they would have no role in any import plan.
The remaining companies are members of the Association quebecoise des distributeurs en pharmacie, which takes the same position as CAPDM.
“Our members have no intention to sell drugs across the border, particularly in light of the rapidly increasing drug shortages in the Quebec marketplace,” said director general Hugues Mousseau in a statement.
http://torontosun.com/news/national/canadian-drug-distributors-say-no-to-trump-import-plan






NO NEED to worry about this insulin biz now!


The border is closed!
 

Avro52

Time Out
Mar 19, 2020
3,635
5
36
If they want to reduce drug prices then just copy what we do and many other modern countries do.

A single mass purchaser.
 

Hoid

Hall of Fame Member
Oct 15, 2017
20,408
4
36
Normally that would be called a monopoly and be illegal. Unless the government does it.
Big insurance companies do it. That's what drug plans are: where you become one of many people contributing to a single company that then offers drugs at a discount because they buy in large quantites.
 

spilledthebeer

Executive Branch Member
Jan 26, 2017
9,296
4
36
Communist.

Let Canadian companies charge whatever prices seem good to them.




POOR T-bonesforbrains! He is OBLIVIOUS AS USUAL!


NAFTA SPECIFICALLY FORBIDS charging Yankees a different price for a product than what a Cdn would pay


for the same item in the same store!
 

spilledthebeer

Executive Branch Member
Jan 26, 2017
9,296
4
36
Normally that would be called a monopoly and be illegal. Unless the government does it.




Yeah! Funny how that works isnt it!



Our provincial govts buy drugs in bulk and sell smaller amounts of that bulk buy to individuals!


Provincial govts can sell to us at a BETTER PRICE than what Yankees can get!


Hence the Yankee interest in buying Insulin from the Cdn provincial monopoly!
 

taxslave

Hall of Fame Member
Nov 25, 2008
36,362
4,340
113
Vancouver Island
Um. . . yes. The same government that passes laws against monopolies can put exceptions in those laws.
You really don't have the first clue how all this works, do you?
Oh I know exactly how it works.One law for us and one law for them. Only by sheer accident to the two coexist.
 

spilledthebeer

Executive Branch Member
Jan 26, 2017
9,296
4
36
Oh I know exactly how it works.One law for us and one law for them. Only by sheer accident to the two coexist.






Is it not amusing that the more frequently T-bonesforbrains lectures us on "how things work" the easier it is to see


THAT HE HAS NOT GOT A CLUE how things work!